Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices 15429 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60–Day–22–0234; Docket No. CDC–2022– 

0038] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled the National Ambulatory Medical 

Care Survey (NAMCS). The goal of this 

project is to assess the health of the 

population through patient use of 

physician and advanced practice 

provider offices and health centers 

(HCs), and to monitor the characteristics 

of physician and provider practices. 

DATES: CDC must receive written 

comments on or before May 17, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0038 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Ambulatory Medical Care 

Survey (NAMCS) (OMB Control No. 

0920–0234, Exp. 07/31/2024)— 

Revision—National Center for Health 

Statistics (NCHS), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The National Ambulatory Medical 

Care Survey (NAMCS) was conducted 

intermittently from 1973 through 1985, 

and annually since 1989. The survey is 

conducted under authority of Section 

306 of the Public Health Service Act (42 

U.S.C. 242k). NAMCS is part of the 

ambulatory care component of the 

National Health Care Surveys (NHCS), a 

family of provider-based surveys that 

capture health care utilization from a 

variety of settings, including hospital 

inpatient and long-term care facilities. 

NCHS surveys of health care providers 

include NAMCS, the National Hospital 

Ambulatory Medical Care Survey 

(NHAMCS) (OMB Control No. 0920– 

0278, Exp. 09/30/2023), the National 

Hospital Care Survey (NHCS) (OMB 

Control No. 0920–0212, Exp. 03/31/ 

2022), and National Post-acute and 

Long-term Care Study (NPALS) (OMB 

Control No. 0920–0943, Exp. 09/30/ 

2023). 

An overarching purpose of NAMCS is 

to meet the needs and demands for 

statistical information about the 

provision of ambulatory medical care 

services in the United States; this fulfills 

one of NCHS’ missions, to monitor the 

nation’s health. In addition, NAMCS 

provides ambulatory medical care data 

to study: (1) Performance of the U.S. 

health care system, (2) care for the 

rapidly aging population, (3) changes in 

services such as health insurance 

coverage change, (4) introduction of 

new medical technologies, and (5) use 

of electronic health records (EHRs). 

Ongoing societal changes have led to 

considerable diversification in the 

organization, financing, and 

technological delivery of ambulatory 

medical care. This diversification is 

evidenced by the proliferation of 

insurance and benefit alternatives for 

individuals, the development of new 

forms of physician group practices and 

practice arrangements (such as officebased practices owned by hospitals), the 

increasing role of advanced practice 

providers delivering clinical care, and 

growth in the number of alternative sites 

of care. 

Ambulatory services are rendered in a 

wide variety of settings, including 

physician/provider offices and hospital 

outpatient and emergency departments. 

Since more than 65% of ambulatory 

medical care visits occur in physician 

offices, NAMCS provides data on the 

majority of ambulatory medical care 

services. In addition to health care 

provided in physician offices and 

outpatient and emergency departments, 

health centers (HCs) play an important 

role in the health care community by 

providing care to people who might not 

be able to afford it otherwise. HCs are 

local, non-profit, community-owned 

health care settings, which serve 

approximately 28 million individuals 

throughout the United States. 

This Revision seeks approval to 

conduct changes to all three 

components of NAMCS. We plan to 

adjust the HC Component and Provider 

Interview sample sizes. In 2022 the goal 

is to sample 5,000 physicians, 5,000 

advanced practice providers, and 110 

HCs. In 2023, we plan to sample up to 

10,000 physicians, 20,000 advanced 


jspears on DSK121TN23PROD with NOTICES1
15430 Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices 

practice providers, and 210 HCs, if 

funds allow. Lastly, if funds allow, in 

2024 we will sample up to 20,000 

physicians, 40,000 advanced practice 

providers, and 310 HCs. For 2022–2024, 

there will be an additional 3,000 

physicians sampled yearly for the 

Provider Electronic Component. 

Questions on the Health Center Facility 

Interview will be modified. After 2021, 

the Physician Induction Interview will 

shift to a redesigned Ambulatory Care 

Provider Interview. Visit data collection 

via abstraction will be placed on a hold 

and the reinterview study will be 

discontinued. The provider incentive 

experiment will also no longer be taking 

place, as we will begin to conduct other 

methodological work to improve upon 

the survey. 

CDC requests OMB approval for an 

estimated 32,302 annual burden hours. 

There are no costs to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hrs.) 

Total burden 

(in hrs.) 

Physician or Staff .............................. Office-Based Physician Induction 

Interview.

500 1 30/60 250 

Reinterview Study ............................ 42 1 15/60 11 

HC’s Staff .......................................... Prepare and transmit EHR for Visit 

Data (quarterly).

17 4 60/60 68 

Set-up fee questionnaire .................. 17 1 15/60 4 

Physician or Staff .............................. ACPI ................................................. 11,667 1 30/60 5,834 

Advanced Practice Provider or Staff ACPI ................................................. 21,667 1 30/60 10,834 

Ambulatory Care Provider’s or 

Group’s or Conglomerate’s Staff.

PFI ....................................................

Prepare and transmit Electronic Visit 

Data (quarterly).

3,000 

3,000 

1 

4 

45/60 

60/60 

2,250 

12,000 

HC’s Staff .......................................... HC Facility Interview ........................ 210 1 45/60 158 

Prepare and transmit EHR for Visit 

Data (quarterly).

210 4 60/60 840 

Set-up fee questionnaire .................. 210 1 15/60 53 

Total ........................................... ........................................................... ........................ ........................ ........................ 32,302 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–05757 Filed 3–17–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–1262] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Barriers and 

Facilitators to Expanding the NHBS to 

Conduct HIV Behavioral Surveillance 

Among Transgender Women (NHBSTrans) to the Office of Management and 

Budget (OMB) for review and approval. 

CDC previously published a ‘‘Proposed 

Data Collection Submitted for Public 

Comment and Recommendations’’ 

notice on November 2, 2021 to obtain 

comments from the public and affected 

agencies. CDC received four comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Barriers and Facilitators to Expanding 

the NHBS to Conduct HIV Behavioral 

Surveillance Among Transgender 

Women (NHBS-Trans) (OMB Control 

No. 0920–1262, Exp. 4/30/2022)— 

Revision—National Center for HIV, 

Viral Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The purpose of this project is to 

demonstrate the feasibility of a national 

surveillance system to monitor 

behaviors of transgender women that are 

related to Human Immunodeficiency 

Virus (HIV) transmission and 

prevention in the United States. 

Findings of the NHBS-Trans project will 


jspears on DSK121TN23PROD with NOTICES1